University of Paris-Saclay-ko ikertzaileekin lankidetzan egindako argitalpenak (1)

2014

  1. The circadian rest-activity rhythm, a potential safety pharmacology endpoint of cancer chemotherapy

    International Journal of Cancer, Vol. 134, Núm. 11, pp. 2717-2725